Goldberg Jeff Marc 4
4 · AKCEA THERAPEUTICS, INC. · Filed Apr 9, 2019
Insider Transaction Report
Form 4
Goldberg Jeff Marc
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2019-04-05$6.48/sh+30,000$194,400→ 32,880 total - Exercise/Conversion
Stock Option (right to buy)
2019-04-05−30,000→ 322,250 totalExercise: $6.48Exp: 2025-12-15→ Common Stock (30,000 underlying) - Sale
Common Stock
2019-04-05$31.71/sh−30,000$951,300→ 2,880 total - Exercise/Conversion
Common Stock
2019-04-08$6.48/sh+20,000$129,600→ 22,880 total - Sale
Common Stock
2019-04-08$31.72/sh−20,000$634,418→ 2,880 total - Exercise/Conversion
Stock Option (right to buy)
2019-04-08−20,000→ 302,250 totalExercise: $6.48Exp: 2025-12-15→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The weighted average sale price for the transaction reported was $31.7209, and the range of prices were between $31.71 and $31.85. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The shares vest as follows: 1/4th of the shares vest one year after January 5, 2015; 1/48th of the shares vest monthly thereafter over the next three years.